Rabbit Monoclonal Antibodies for Human IgG Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for evaluating therapeutic antibody pharmacokinetics and pharmacodynamics in preclinical studies rely on laborious and time-consuming drug-specific anti-idiotype antibodies, and there is a lack of universal reagents that can accurately measure human IgG-derived monoclonal antibodies in non-human primates due to high sequence homology with monkey immunoglobulins.
Innovation Solution
Development of isolated monoclonal antibodies or antigen-binding portions that specifically bind to human IgG, comprising specific heavy and light chain complementarity-determining regions (CDRs), which are designed to avoid binding to monkey IgG, thereby enabling accurate measurement of human therapeutic antibodies in non-human primate samples.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If drug-specific anti-idiotype antibodies are used to evaluate therapeutic antibody pharmacokinetics and pharmacodynamics, then measurement specificity for the therapeutic antibody is improved, but the development process becomes laborious and time-consuming
Solution Approach 1:
The patent applies universality by developing a single rabbit polyclonal antibody reagent that can detect multiple human IgG-based therapeutic antibodies across different drug candidates. This universal reagent eliminates the need to develop separate anti-idiotype antibodies for each therapeutic antibody, thereby reducing development time while maintaining measurement specificity through the use of human IgG-specific epitopes that are conserved across therapeutic molecules.
2Measurement precision
If rabbit polyclonal antibodies are used to detect human IgG in non-human primate serum, then measurement sensitivity is improved, but cross-reactivity with monkey immunoglobulins occurs due to high sequence homology
Solution Approach 1:
The patent applies local quality by targeting specific epitopes on the Fc region of human IgG that are locally distinct from monkey IgG sequences. The rabbit polyclonal antibody is raised against human IgG and specifically recognizes epitopes that are conserved in human IgG but differ from monkey IgG sequences, thereby achieving high measurement sensitivity for human therapeutic antibodies while maintaining specificity by avoiding cross-reactivity with monkey immunoglobulins despite overall sequence homology.
3Productivity
If universal reagents are developed to detect all human IgG-based therapeutic antibodies, then development efficiency is improved, but reagent specificity for distinguishing human from monkey immunoglobulins becomes difficult to achieve
Solution Approach 1:
The patent applies parameter changes by modifying the antibody reagent characteristics - specifically using a rabbit polyclonal antibody raised against human IgG with optimized affinity and specificity parameters. The reagent is characterized to recognize human IgG epitopes with high affinity while having minimal cross-reactivity with monkey IgG, achieving both development efficiency through universality and measurement precision through carefully controlled specificity parameters.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The described rabbit monoclonal antibodies demonstrate high affinity and specificity for human IgG, with no detectable binding to cynomolgus monkey IgG, facilitating accurate detection and measurement of human therapeutic antibodies in preclinical studies, thereby improving the efficiency and accuracy of pharmacokinetic and pharmacodynamic evaluations.
Implementation Method 1
The present disclosure provides isolated monoclonal antibodies or antigen-binding portions thereof that bind specifically to human IgG
Data Source
AI summary
This disclosure anti-human IgG antibodies and antigen-binding portions thereof derived from rabbits and methods of using these antibodies and portions.